SDSDownload

Eprosartan Related Compound E / 15 MG

Purity: 98% (TLC)
Synonym: HMBA; 4-Carboxybenzylalcohol; 4-Hydroxythylbenzoic acid; 4-Hydroxymethylbenzoic acid
Molecular Formula: C8H8O3
Molecular Weight: 152.15
SKU: MND-23830
CAS Number: 3006-96-0
MDL number: MFCD00017598
Form: powder
Note: Prices are for comparison only. Contact Sales for current pricing.
Packing size: 15 MG  
606.90 EUR


Properties

Flash Point (C)Not available
Flash Point (F)Not available
Melting Point182-185 °C (lit.)

 Product Description

4-(Hydroxymethyl)benzoic acid is a derivative of benzoic acid featuring a hydroxymethyl group. It is utilized in the synthesis of various organic compounds due to its reactive functionality. This compound is particularly useful in the production of pharmaceuticals, where it can serve as a precursor to more complex molecules with therapeutic properties. Additionally, its acidic nature makes it valuable in the preparation of esters and amides, expanding its applicability in chemical synthesis.

 

Application:

Used in the pharmaceutical industry for the synthesis of active pharmaceutical ingredients (APIs). Its versatility in chemical reactions enables the production of a wide range of compounds with potential therapeutic benefits. Also applicable in the preparation of esters and amides for use in various industrial processes.

 

 

Articles:

- HMBA ameliorates obesity by MYH9‐ and ACTG1‐dependent regulation of hypothalamic neuropeptides

Publication Date: 20 November 2023

Seokjae Park, Sungjoon Oh, Nayoun Kim and Eun‐Kyoung Kim

https://doi.org/10.15252/emmm.202318024

 

- The role of the Aspergillus nidulans high mobility group B protein HmbA, the orthologue of Saccharomyces cerevisiae Nhp6p

Publication Date: 15 October 2022

Judit Ámon, Gabriella Varga, Ilona Pfeiffer, Zoltán Farkas, Zoltán Karácsony, Zsófia Hegedűs, Csaba Vágvölgyi & Zsuzsanna Hamari

https://doi.org/10.1038/s41598-022-22202-3

 

- Anti-Cancer Drug HMBA Acts as an Adjuvant during Intracellular Bacterial Infections by Inducing Type I IFN through STING

Publication Date: OCTOBER 01 2017

Akshamal Mihiranga Gamage; Kok-Onn Lee ; Yunn-Hwen Gan

https://doi.org/10.4049/jimmunol.1602162